Inside Reproductive Health Podcast

What’s the definition of a cartel, and has the way we pay for care created one in fertility? This week on Inside Reproductive Health , two practice-owning REIs with very different models join Griffin to push that question hard. Dr. Robert Kiltz (CNY Fertility) and Dr. Francisco Arredondo (Pozitvf IVF & The IVF Academy) dig into the economics, the ethics, and the possible alternatives to the st...

If you’ve ever tried to get doctors, embryologists, and executives on the same page…you’ll want to hear this one. In this episode of Inside Reproductive Health , Dr. Alison Bartolucci (CSO) and Cara Reymann (CEO) of First Fertility talk candidly about leadership, lab management, and network-wide decision-making. They discuss: – The emotional cost of leading a fertility network – When to build cons...

Overwhelm. Anxiety. Cases that stay with you. That’s how some of the field’s most experienced professionals describe genetics in reproductive medicine today. In this episode of Inside Reproductive Health , we brought together leaders from RMA, CCRM, Shady Grove, and GeneScreen to talk about the genetics overload in modern ART. They talk with Griffin about: The liability landmine that genetics has...

Doctors used to dream not just of earning well, but of controlling how they practiced and how they cared for patients. Doctors Cristin Slater, Kevin Maas, and Kyle Tobler—partners at the independently owned Idaho Center for Reproductive Medicine—explain why that dream feels so far away for many. Here’s what we cover: Why Dr. Maas says he’d never go back to a private equity-owned network Hidden leg...

Beth Zoneraich, CEO of Pinnacle Fertility, is back on Inside Reproductive Health to share the hard numbers and the deeper philosophy behind what she calls the Pinnacle Operational Model. We deep dive into:: Why they automate the back end of patient care ( but never the front ) How 3,000 unanswered phone calls became 500 new patients The “J curve” of operational change ( where things get worse befo...

With a very limited number of genetic counselors nationwide, it’s impossible for every fertility patient to see one. Clinics like RMA New York are getting strategic. In this week’s episode of Inside Reproductive Health, genetic counselor Teresa Cacchione explains why genetic counseling in IVF is becoming increasingly critical and complex. Teresa discusses: Why and how RMA-NY relies on a partner ca...

They were lucky. The gas to the incubator stopped flowing , but XiltriX caught the failure in time, no embryos were lost… and no headlines were made. But what happens if the next failure isn’t? In this episode, Dr. Matthew “Tex” VerMilyea of Ovation and US Fertility, and Moises Eilemberg, CEO of XiltriX North America, return to Inside Reproductive Health to ask a hard question: What would your lab...

What happens when managed care surges in IVF, reimbursements drop, and physicians are expected to do more work for less ? Dr. Ravi Gada and Manish Chhadua are back on the show, and they don’t hold back. Dr. Gada is a partner at one of the largest independently owned practices in the United States and he and Manish co-own and operate a firm called CloudRx,  In this episode, they dig into: What 70 f...

From a founding partner about to retire, to an associate just out of fellowship, all five REIs at Carolina Conceptions sat down to share their takes on staying private, staying aligned, and staying real. Carolina Conceptions invited us in, and we talked real talk about: The golden parachute of private equity ( and why they’ve resisted it ) The tension between high-touch care and the operational de...

I've captured and interrogated one of fertility doctors’ enemies…a lawyer. But this one’s on your side. Matthew Maruca has served as General Counsel for Inception Fertility since 2019, and he’s here to walk you through the legal threats and legislative currents shaping the future of fertility care.  While this episode isn’t legal advice, Matt brings insight into how reproductive health is bein...

Fertility doctors are burnt out. Not all of them, but enough to warrant a real conversation. Dr. Jason Yeh is a full-time fertility physician, a national medical director, an academic-turned-industry leader—and very much in the thick of this discussion. In this episode, we unpack the often unspoken reality of REI burnout and why so many are struggling to stay engaged after a decade in the field. I...

What if your clinic could see 80 new patients while saving 80 hours of physician time… per doctor… per month? That’s what Dr. Mark Amols and his team at New Direction Fertility Center are working toward—while maintaining a 9 out of 10 rating across hundreds of patient reviews. In this episode, you’ll hear: The top-of-license model ( From REIs to admin staff ) How to structure visits to dramaticall...

Where do business insight and patient experience come together? In this week’s episode, Dr. Eduardo Hariton shares his POV on cost reductions, business opportunities, and what fertility tech gets right ( and wrong ) when designing for doctors and patients alike. We talk about: 70% or 10%, differences in IVF conversion rate How to reduce patient drop out How to measure real IVF conversion rates Whe...

What if 25–35% of patients in the U.S., Canada, or Europe left for equal-quality IVF at a quarter of the cost? In this episode we take you back to Mexico City, round zero for what may be the next global IVF surge. Juan Moctezuma, Co-Founder and Co-CEO of Reina Madre, and Daniel Madero, CEO of Fertilidad Integral, join the show to discuss: The hub-and-spoke model fueling their growth How they plan...

IVIRMA is so big, they had 1,400 people just at their international congress. But what does it take to implement change, scale care, and keep the patient experience high inside an organization that large? This week’s guest, Dr. Thomas Molinaro, Chief Medical Officer of IVIRMA North America, shares what’s working, what’s still being figured out, and what challenges fertility networks of every size...

OB/GYNs are entering the IVF space—but what role should they play? This debate is heating up in fertility medicine, and Dr. Stephanie Kuku, a former OB/GYN surgeon in the NHS and now Chief Knowledge Officer at Conceivable Life Sciences, offers her global, tech-forward perspective In this episode, she talks through: What REIs and OB/GYNs really need from each other Where the line is on fertility ca...

What standards should be non-negotiable in IVF labs? In this week’s episode of Inside Reproductive Health, we’re joined by Dr. Sangita Jindal—lab director at five IVF centers and former SART president—to discuss the urgent need for standardized embryologist training, better oversight, and technologies that minimize catastrophic lab errors. Tune in to hear Dr. Jindal’s insights on: Why embryologist...

What’s the biggest thing happening in the IVF lab? It might just be automation. This isn’t hypothetical. It’s operating now. We visited Hope IVF in Mexico City to see AURA, the fully automated IVF lab created by Conceivable Life Sciences. We sat down with co-founders Joshua Abram, Dr. Alejandro Chavez-Badiola, and Alan Murray to ask the questions you submitted—and some of our own. Tune in as the f...

Looking to hire top REI talent? Want more meaningful conversations with clinic execs and embryologists? There’s one summer meeting that keeps coming up in those conversations: The Midwest Reproductive Symposium International ( MRSi ) . In this episode of Inside Reproductive Health , we’re joined by three of its organizers; Dr. GG Collins, Dr. Eric Forman, and Dr. Morgan Wilhoite—who share how they...

Everyone wants to grow their third party IVF program, but are we neglecting patient experience in the process? This week on Inside Reproductive Health , Eloise Drane, 3 time gestational carrier, MBA, and founder of Family Inceptions, shares her honest take on how responsiveness and individualized care have declined , even as demand has stabilized post-2021. Drawing from 17 years of experience runn...

What’s your exit strategy? For single providers and small fertility practice owners, the difference between a multimillion-dollar sale and walking away with nothing often comes down to timing and preparation. This week on Inside Reproductive Health , I sit down with Bob Goodman, Richard Groberg, and Dr. Brijinder Minhas of MidCap Advisors to discuss: The current state of fertility clinic mergers &...

Genetics is nobody’s baby—or at least this week’s guest seems to think so. Dr. Mili Thakur, an REI, geneticist, and consultant through Genome Ally, joins us to break down the gaps in genetic testing, the impact on patient care, and why ASRM and others must step up to set industry-wide standards. Tune in to hear: The risks inconsistent genetic testing poses to patients and clinics. How the lack of...

Who’s adding the most value in IVF today—and who might not be here tomorrow? This week on Inside Reproductive Health , Dr. Cristina Hickman, founder of Avenue Center for Reproductive Medicine in London, breaks down the fertility field’s evolving landscape. As a PhD embryologist and clinic owner, she shares her perspective on industry leaders, automation, and the shifting role of technology in fert...

What if 30% of your fertility clinic’s egg retrievals were for egg freezing? That’s the reality at FertGroup in Brazil, where Dr. Marcus Dantas Martins, Chief Operating Officer, is leading a transformative approach to fertility care. In this episode, Dr. Dantas reveals how Fert Group is leveraging technology and private equity to expand their influence in the rapidly growing Brazilian market. Join...

Lynn Mason, CEO of IVI RMA North America, provides an inside look at how dyad leadership—integrating physician leaders with business leaders—drives innovation and collaboration across IVI RMA Global, Boston IVF Trio, and other key partners. She discusses how their in-house EMR system is used for patient triage and emphasizes the importance of collecting the right data. With Mason, we explore: Leve...